In medicine and biology, “vascular” refers to anything related to the vessels that carry fluids through a living organism. In humans, that primarily means blood vessels: arteries, veins, and the tiny capillaries connecting them. But the term reaches further than the human bloodstream. Lymphatic channels, the water-conducting tubes inside a fern stem, and even the leaky vessels feeding a tumor all fall under the vascular umbrella, and the word shows up across specialties from cardiology to botany to cancer therapy.
Arteries, Veins, Capillaries, and the Endothelium
The human vascular system is a closed loop of vessels that keeps blood circulating. Arteries carry oxygen-rich blood away from the heart, branching into smaller and smaller vessels until they become capillaries, where oxygen and nutrients actually pass into tissues. Veins then collect the oxygen-depleted blood and return it to the heart. Together, these vessels stretch tens of thousands of miles in an adult body.
What makes vessels more than passive tubes is the endothelium, the single-cell-thick lining on their inner surface. Endothelial cells actively regulate how wide a vessel opens, how easily blood clots form, and how much inflammation occurs in the vessel wall. When this lining works properly, it promotes what researchers call an “atheroprotective environment,” essentially keeping vessels smooth, flexible, and resistant to plaque buildup.1Europe PMC. The endothelium and its role in regulating vascular tone When endothelial cells stop functioning well, the consequences ripple outward into conditions like high blood pressure, blood clots, and heart disease.
How New Blood Vessels Form
Your body doesn’t just build its vascular network once and leave it alone. Two distinct processes create and expand blood vessels over a lifetime. Vasculogenesis is the formation of brand-new vessels from scratch, which happens mainly during embryonic development when precursor cells organize themselves into the first tubes. Angiogenesis is the sprouting of new branches from vessels that already exist, and it continues throughout life: wounds heal partly because capillaries grow into damaged tissue, and exercise can stimulate new vessel formation in working muscles.2PubMed Central. Signal transduction in vasculogenesis and developmental angiogenesis
Both processes require precise coordination among multiple cell types, and when that coordination goes wrong, the results can be serious. Insufficient angiogenesis means wounds that won’t close and tissues starved of oxygen. Excessive or misdirected angiogenesis feeds tumors, a point we’ll return to later.
The Lymphatic Vessels
Blood vessels get most of the attention, but the lymphatic system is a parallel vascular network that is just as essential. Fluid constantly leaks out of capillaries into the spaces between cells. If it just accumulated there, tissues would swell and eventually fail. Lymphatic vessels gather this interstitial fluid, filter it through lymph nodes where immune cells can screen it for threats, and return it to the bloodstream.
Getting that fluid back into the veins is a surprising engineering challenge. The fluid in tissues is often at below-atmospheric pressure, while the veins it needs to re-enter sit at roughly 20 centimeters of water pressure.3PubMed Central. Lymphatic System Flows Lymphatic vessels overcome this pressure difference by actively pumping: their walls contain contractile muscle cells, and closely spaced one-way valves keep the fluid moving in the right direction. Beyond fluid balance, the lymphatic system also clears metabolic waste and dead-cell debris from tissues and plays a central role in mounting immune responses against bacteria, viruses, and parasites.4PubMed Central. Lymphatic Vessel Network Structure and Physiology
Vascular Tissue in Plants
The word “vascular” is not limited to animals. In botany, vascular plants are defined by having specialized transport tissues: xylem and phloem. Xylem moves water and dissolved minerals upward from the roots, while phloem distributes sugars produced by photosynthesis and signaling molecules throughout the plant.5PubMed Central. Plant vascular development: mechanisms and environmental regulation Both arise from a layer of stem cells called the cambium, which sits between them and keeps producing new transport cells as the plant grows.
This innovation was a turning point in the history of life on land. Non-vascular plants like mosses and liverworts rely on direct cell-to-cell diffusion for water, which limits their size and confines them to damp environments. Vascular tissue allowed plants to grow tall, colonize dry habitats, and eventually form forests. The fossil record suggests that transporting tissues evolved gradually: the earliest land plant fossils with recognizable conducting cells date back roughly 440 million years, and the more specialized cells seen in modern ferns and trees had appeared by about 425 million years ago.6PubMed Central. Deep origin and gradual evolution of transporting tissues: Perspectives from across the land plants
Invertebrate Circulatory Systems and the “Open vs. Closed” Debate
Textbooks often draw a sharp line between “open” circulatory systems in insects and crustaceans and “closed” systems in vertebrates. In the traditional picture, open systems are sluggish and poorly regulated, with blood simply pooling around organs in loose cavities. That picture turns out to be too simple. Many invertebrates have evolved partially or completely cell-lined vessels with highly branched networks capable of generating significant blood pressures and flow rates to support active lifestyles.7International Journal of Zoology. A Review of the “Open” and “Closed” Circulatory Systems: New Terminology for Complex Invertebrate Circulatory Systems in Light of Current Findings Some cephalopods, for instance, have circulatory systems that are functionally quite sophisticated. The clean dichotomy between “open” and “closed” is really more of a spectrum, and calling one type inherently inferior misses the evolutionary diversity of vascular solutions across the animal kingdom.
Places Where Blood Vessels Don’t Go
Not every tissue in the human body has a blood supply, and these avascular tissues depend on diffusion from nearby vessels for survival. The most familiar example is articular cartilage, the smooth covering on the ends of bones inside joints. Because cartilage lacks its own vessels, nutrients seep in slowly from surrounding tissue and from joint fluid.8PubMed Central. TRANSPORT PROPERTIES OF CARTILAGINOUS TISSUES The cornea of the eye is another avascular tissue, nourished entirely by diffusion.9Nature. Structure and Nutrition of the Cornea, Cartilage and Wharton’s Jelly
This design has trade-offs. Avascular tissues are transparent or mechanically resilient precisely because they lack the disruption of blood vessel walls. But the same absence of direct blood supply means they heal poorly when injured and are vulnerable to degeneration if nutrient diffusion is compromised. Osteoarthritis and disc degeneration are both thought to stem in part from this nutritional vulnerability.8PubMed Central. TRANSPORT PROPERTIES OF CARTILAGINOUS TISSUES When someone says a knee injury “won’t heal on its own,” the avascular nature of cartilage is a big reason why.
Atherosclerosis and Vascular Disease
When doctors talk about “vascular disease,” they most commonly mean atherosclerosis, the gradual buildup of fatty plaques inside artery walls. The process starts with damage or dysfunction of the endothelium. Lipids, particularly LDL cholesterol, accumulate in the vessel wall and trigger inflammation. Over time, fibrous tissue, calcium deposits, and dead cells pile up to form a plaque that narrows the artery and stiffens its wall.10PubMed Central. Pathophysiology of Atherosclerosis Atherosclerosis is driven by lipoproteins and sustained by inflammation, with the plaques developing at particular sites in the arterial tree where blood flow patterns create turbulence.11PubMed. Mechanisms of plaque formation and rupture
The consequences depend on where the plaque sits. In the coronary arteries, it causes heart attacks. In the arteries feeding the brain, it causes strokes. In the legs, it causes peripheral artery disease, which can lead to pain while walking and, in severe cases, limb loss. This is why vascular health is not a single organ problem but a whole-body concern.
Diabetes and the Macro-Micro Divide
Diabetes illustrates how vascular damage can be both large-scale and microscopic at the same time. Clinicians split diabetic vascular complications into two categories: macrovascular events, which affect large and medium arteries, and microvascular events, which damage tiny vessels in the eyes, kidneys, and nerves.
A large study of U.S. Medicare patients with type 2 diabetes found that macrovascular events, things like coronary heart disease and peripheral artery disease, occurred at a rate of about 484 per 10,000 person-years. Microvascular complications were far more common, at roughly 1,569 per 10,000 person-years. In patients who already had established cardiovascular disease, both rates climbed higher. Neuropathy and nephropathy were the most frequent microvascular problems, each affecting roughly 7 to 10 percent of patients within a single year.12PubMed Central. Macrovascular and microvascular complications in US Medicare enrollees with type 2 diabetes with and without atherosclerotic cardiovascular disease The distinction matters practically because the treatments and monitoring for large-vessel disease and small-vessel disease differ, even though both stem from the same metabolic problem.
The Blood-Brain Barrier as a Vascular Specialty
Not all capillaries are the same. The capillaries in the brain are unusually selective about what they let through, forming what is known as the blood-brain barrier. This barrier exists because brain endothelial cells are sealed together much more tightly than those in the rest of the body, supported by pericytes that wrap around the outside of vessels and astrocytes that extend projections to cover nearly the entire vessel surface. Together with neurons and other glial cells, these components form the neurovascular unit, a structure that controls what crosses from the bloodstream into brain tissue.13PubMed Central. Research developments in the neurovascular unit and the blood‑brain barrier
The blood-brain barrier protects the brain from toxins, pathogens, and even many drugs. That protective function is a double-edged sword in medicine: it keeps harmful substances out, but it also keeps therapeutic drugs out, which is a major hurdle in treating brain cancers, Alzheimer’s disease, and other neurological conditions. A large share of drug-development research in neurology is focused on finding ways to temporarily or selectively open this vascular gate.
How Tumors Hijack Blood Vessel Growth
Tumors cannot grow beyond a tiny size without recruiting their own blood supply. They do this by secreting chemical signals, most prominently vascular endothelial growth factor (VEGF), that stimulate nearby vessels to sprout new branches toward the tumor. This process, tumor angiogenesis, provides the oxygen and nutrients a growing cancer needs.
Anti-angiogenic therapy aims to cut off that supply. Most approved anti-angiogenic drugs work by blocking the VEGF signaling pathway, and they have been a treatment option for various cancers for about two decades.14PubMed Central. Tumor angiogenesis and anti-angiogenic therapy Beyond starving tumors of nutrients, these drugs can also enhance the effectiveness of immunotherapy, since VEGF has immune-suppressing effects.15PubMed Central. Anti-Angiogenic Therapy: Current Challenges and Future Perspectives Despite real clinical benefits, anti-angiogenic drugs rarely cure cancers on their own, and tumors often find alternative routes to regain a blood supply. Developing more effective next-generation drugs in this space remains an active area of research.
Tumor Vasculature and Drug Delivery
The blood vessels that tumors build are structurally abnormal: leakier and more chaotic than normal capillaries. Researchers noticed decades ago that large molecules tend to accumulate in tumor tissue because they slip through these porous vessel walls and then stay put, since tumors have poor lymphatic drainage to clear them out. This phenomenon is known as the enhanced permeability and retention effect, or EPR effect, and it became the theoretical basis for designing nano-sized cancer drugs that would selectively concentrate in tumors.16PubMed Central. The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application
The idea sounds elegant, but the clinical reality is more sobering. While nanoparticle drugs do accumulate in tumor tissue with reduced side effects elsewhere, the actual increase in drug delivery compared to critical normal organs is less than twofold, which often is not enough to cure the cancer.17PubMed Central. Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? The EPR effect varies enormously between patients and even between different parts of the same tumor, so a drug that accumulates well in one person’s cancer may barely reach another’s. Researchers continue working to improve nanoparticle designs and combine them with strategies that normalize or further permeabilize tumor vessels to boost delivery.18Applied Drug Research, Clinical Trials and Regulatory Affairs. Utilization of Nanoparticles in Transdermal Drug Delivery Exploiting Enhanced Permeability and Retention Effect for Cancer Targeting
How Doctors Look at Your Vessels
When a clinician suspects vascular disease, there are several imaging tools to see what’s happening inside your vessels. Doppler ultrasound is often the first step because it’s non-invasive and inexpensive. It uses sound waves to measure how fast blood is flowing and can identify blockages by changes in velocity. CT angiography provides more detailed three-dimensional images of the arteries and is used to localize the exact position and severity of narrowing. For definitive mapping, especially before a surgical procedure, conventional digital subtraction angiography remains the reference standard.19Journal for Vascular Ultrasound. The Role of Doppler Ultrasound, CT Angiography, and Conventional Angiography in Detection of Peripheral Arterial Disease
Newer ultrasound techniques are pushing the technology further, incorporating approaches like elastography to measure vessel wall stiffness, slow-flow imaging to detect blood movement in very small vessels, and contrast-enhanced ultrasound for more detailed visualization. These advances offer insights into conditions like vascular aging, where arteries gradually stiffen and lose their ability to expand and contract normally.20PubMed Central. Recent advances in vascular ultrasound imaging technology and their clinical implications
Vascular Access for Medical Treatment
The word “vascular” also comes up in a very practical clinical context: vascular access, meaning the creation of a reliable entry point into the bloodstream. This matters most for patients on hemodialysis, who need high-flow blood access several times a week. The three main types of permanent vascular access for hemodialysis are arteriovenous fistulas, where a surgeon connects an artery directly to a vein to enlarge it; arteriovenous grafts, where a synthetic tube bridges the artery and vein; and central venous catheters inserted into large veins in the neck or chest.21PubMed Central. Overview of hemodialysis access and assessment
Each type comes with its own complications. Fistulas can develop aneurysms or clots. Catheters carry infection risk and can cause vein narrowing. A condition called steal syndrome can occur when the fistula diverts too much blood away from the hand, causing pain or numbness. Choosing the right type of access for a particular patient involves weighing their anatomy, life expectancy, and personal circumstances. Research comparing different fistula locations, for instance, has found that fistulas placed in the proximal radial artery carry a lower risk of steal syndrome than those placed higher up the arm, making them preferable when anatomically feasible.22Journal of Surgery and Trauma. Comparing the outcomes of proximal radial artery arteriovenous fistula and brachio-cephalic arteriovenous fistula for hemodialysis vascular access
Engineering Blood Vessels From Scratch
One of the biggest challenges in tissue engineering is building a functional network of blood vessels inside lab-grown tissues. Without vessels, engineered tissue thicker than a fraction of a millimeter starves and dies, because nutrients can only diffuse so far. Researchers have turned to 3D bioprinting to tackle this, using techniques that deposit living cells and supportive biomaterials in precise patterns to mimic the branching architecture of real blood vessels.23PubMed Central. Bioprinting in Vascularization Strategies
Several printing methods are being explored, including extrusion-based printing that pushes cell-laden inks through a nozzle and laser-based sintering that fuses material with pinpoint accuracy. The goal is to create channels that living cells can colonize and remodel into functional vessels after implantation. Progress has been real but incremental: small-scale vascularized tissue patches have been printed and tested in animal models, though printing a full organ with a complete and functional vascular tree remains a long way off. If it succeeds, it would address the organ-transplant shortage by allowing doctors to grow replacement tissues that already have the blood supply they need to survive.